Potential role of Thymosin- 1 adjuvant therapy for glioblastoma

Journal of Oncology

Volumn , Issue , 2009, Pages

  De La Monte, Suzanne M ^a   Sungarian, Arno ^a   Cielo, Deus ^a   Sampath, Prakash ^a   Bowling, Nathaniel ^a   Moskal, Peter ^a   Wands, Jack R ^a,b  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; GRANZYME B; THYMOSIN ALPHA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG MEGADOSE; GLIOBLASTOMA; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; LOW DRUG DOSE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

EID: 76349083145     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/302084     Document Type: Article

References (59)

1. Burton E. C., Prados M. D., Malignant gliomas Current Treatment Options in Oncology 2000 1 5 459 468
2. Gal H., Makovitzki A., Amariglio N., Rechavi G., Ram Z., Givol D., A rapid assay for drug sensitivity of glioblastoma stem cells Biochemical and Biophysical Research Communications 2007 358 3 908 913
3. Kleihues P., Louis D. N., Scheithauer B. W., The WHO classification of tumors of the nervous system Journal of Neuropathology and Experimental Neurology 2002 61 3 215 229
4. Macdonald D. R., Temozolomide for recurrent high-grade glioma Seminars in Oncology 2001 28 4, supplement 13 3 12
5. Prados M. D., Levin V., Biology and treatment of malignant glioma Seminars in Oncology 2000 27 3, supplement 6 1 10
6. Nieder C., Grosu A. L., Molls M., A comparison of treatment results for recurrent malignant gliomas Cancer Treatment Reviews 2000 26 6 397 409
7. Napolitano M., Keime-Guibert F., Monjour A., Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study Journal of Neuro-Oncology 1999 45 3 229 235
8. Dazzi C., Cariello A., Giannini M., A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study Anticancer Research 2000 20 1B 515 518
9. Back M. F., Ang E. L. L., Ng W.-H., Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy Annals of the Academy of Medicine Singapore 2007 36 5 338 342
10. Dix A. R., Brooks W. H., Roszman T. L., Morford L. A., Immune defects observed in patients with primary malignant brain tumors Journal of Neuroimmunology 1999 100 1-2 216 232
11. Roth W., Weller M., Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives Cellular and Molecular Life Sciences 1999 56 5-6 481 506
12. Sablotzki A., Ebel H., Muhling J., Dysregulation of immune response following neurosurgical operations Acta Anaesthesiologica Scandinavica 2000 44 1 82 87
13. Billich A., Thymosin L. SciClone Pharmaceuticals Current Opinion in Investigational Drugs 2002 3 5 698 707
14. Bodey B., Thymic hormones in cancer diagnostics and treatment Expert Opinion on Biological Therapy 2001 1 1 93 107
15. Bodey B., Bodey B. Jr., Siegel S. E., Kaiser H. E., Review of thymic hormones in cancer diagnosis and treatment International Journal of Immunopharmacology 2000 22 4 261 273
16. Andreone P., Cursaro C., Gramenzi A., In vitro effect of thymosin- 1 and interferon- on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C Journal of Viral Hepatitis 2001 8 3 194 201
17. Attia W. Y., Badamchian M., Goldstein A. L., Spangelo B. L., Thymosin stimulates interleukin-6 production from rat spleen cells in vitro Immunopharmacology 1993 26 2 171 179
18. Baxevanis C. N., Frillingos S., Seferiadis K., Enhancement of human T lymphocyte function by prothymosin : increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes Immunopharmacology and Immunotoxicology 1990 12 4 595 617
19. Baxevanis C. N., Gritzapis A. D., Dedoussis G. V. Z., Papadopoulos N. G., Tsolas O., Papamichail M., Induction of lymphokine-activated killer activity in mice by prothymosin Cancer Immunology Immunotherapy 1994 38 4 281 286
20. Beuth J., Schierholz J. M., Mayer G., Thymosin 1 application augments immune response and down-regulates tumor weight and organ colonization in BALB/c-mice Cancer Letters 2000 159 1 9 13
21. Cordero O. J., Sarandeses C. S., Lopez J. L., Nogueira M., Prothymosin enhances human natural killer cell cytotoxicity: role in mediating signals for NK activity Lymphokine and Cytokine Research 1992 11 5 277 285
22. Garbin F., Eckert K., Immenschuh P., Kreuser E. D., Maurer H. R., Prothymosin 1 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients International Journal of Immunopharmacology 1997 19 6 323 332 (Pubitemid 28025428)
23. Knutsen A. P., Freeman J. J., Mueller K. R., Roodman S. T., Bouhasin J. D., Thymosin- 1 stimulates maturation of CD34 + stem cells into CD3 + 4 + cells in an in vitro thymic epithelia organ coculture model International Journal of Immunopharmacology 1999 21 1 15 26
24. Spangelo B. L., Farrimond D. D., Pompilius M., Bowman K.-L., Interleukin-1 and thymic peptide regulation of pituitary and glial cell cytokine expression and cellular proliferation Annals of the New York Academy of Sciences 2000 917 597 607
25. Spangelo B. L., Farrimond D. D., Thapa M., Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro Endocrinology 1998 139 4 2155 2162
26. Tijerina M., Gorospe W. C., Bowman K.-L., Badamchian M., Goldstein A. L., Spangelo B. L., A novel thymosin peptide stimulates interleukin-6 release from rat C6 glioma cells in vitro NeuroImmunoModulation 1997 4 3 163 170
27. Chan H. L.-Y., Tang J.-L., Tam W., Sung J. J.-Y., The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis Alimentary Pharmacology and Therapeutics 2001 15 12 1899 1905
28. Chien R.-N., Lin C.-Y., Yeh C.-T., Liaw Y.-F., Hepatitis B virus genotype B is associated with better response to thymosin 1 therapy than genotype C Journal of Viral Hepatitis 2006 13 12 845 850
29. Ideo G., Bellobuono A., New therapies for the treatment of chronic hepatitis C Current Pharmaceutical Design 2002 8 11 959 966
30. Lau G. K. K., Nanji A., Hou J., Thymosin- 1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase Journal of Viral Hepatitis 2002 9 4 280 287
31. Saruc M., Yuceyar H., Kucukmetin N., Demir M. A., Kandiloglu A. R., Combination thymosin- 1 and interferon- 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey Hepato-Gastroenterology 2002 49 45 798 802
32. Sherman K. E., Jones C. C., Goldstein A. L., Naylor P. H., Low thymosin -1 concentrations in patients chronically infected with the hepatitis B virus Viral Immunology 1991 4 3 195 199
33. Sherman K. E., Sjogren M., Creager R. L., Combination therapy with thymosin 1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial Hepatology 1998 27 4 1128 1135
34. Gramenzi A., Cursaro C., Andreone P., Bernardi M., Thymalfasin: clinical pharmacology and antiviral applications BioDrugs 1998 9 6 477 486
35. Garaci E., Pica F., Rasi G., Favalli C., Thymosin 1 in the treatment of cancer: from basic research to clinical application International Journal of Immunopharmacology 2000 22 12 1067 1076
36. Ji S. M., Li L. S., Sun Q. Q., Chen J. S., Sha G. Z., Liu Z. H., Immunoregulation of thymosin 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation Transplantation Proceedings 2007 39 1 115 119
37. Wang B., He F., Lin Y., Huang M., Zhou S. F., Effect of recombinant human thymosin- 1, an immuno-modulating peptide with 28 amino acids, on the activity of cytochrome P450s Drug Metabolism Letters 2007 1 3 199 204
38. de La Monte S. M., Ganju N., Wands J. R., Microtiter immunocytochemical ELISA assay BioTechniques 1999 26 6 1073 1078
39. de la Monte S. M., Neely T. R., Cannon J., Wands J. R., Ethanol impairs insulin-stimulated mitochondrial function in cerebellar granule neurons Cellular and Molecular Life Sciences 2001 58 12-13 1950 1960
40. Ochel H.-J., Correlation between crystal violet dissolution assay and manual colony counting on the in vitro effects of Hsp90-inhibitors Journal of Experimental Therapeutics and Oncology 2005 5 1 9 13
41. de la Monte S. M., Lahousse S. A., Carter J., Wands J. R., ATP luminescence-based motility-invasion assay BioTechniques 2002 33 1 98 106
42. Davis J. E., Sutton V. R., Smyth M. J., Trapani J. A., Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homology, BHRF1 Cell Death and Differentiation 2000 7 10 973 983
43. Hayashida M., Kawano H., Nakano T., Shiraki K., Suzuki A., Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells Proceedings of the Society for Experimental Biology and Medicine 2000 225 2 143 150
44. Kontani K., Sawai S., Hanaoka J., Tezuka N., Inoue S., Fujino S., Involvement of granzyme B and perforin in suppressing nodal metastasis of cancer cells in breast and lung cancers European Journal of Surgical Oncology 2001 27 2 180 186
45. Pipkin M. E., Lieberman J., Delivering the kiss of death: progress on understanding how perforin works Current Opinion in Immunology 2007 19 3 301 308
46. Simon M. M., Waring P., Lobigs M., Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis Journal of Immunology 2000 165 7 3663 3672
47. Vermijlen D., Froelich C. J., Luo D., Suarez-Huerta N., Robaye B., Wisse E., Perforin and granzyme B induce apoptosis in FasL-resistant colon carcinoma cells Cancer Immunology, Immunotherapy 2001 50 4 212 217
48. Vujanovic N. L., Role of TNF family ligands in antitumor activity of natural killer cells International Reviews of Immunology 2001 20 3-4 415 437
49. Sepe P. S., Lahousse S. A., Gemelli B., Role of the aspartyl-asparaginyl- beta-hydroxylase gene in neuroblastoma cell motility Laboratory Investigation 2002 82 7 881 891
50. Baxevanis C. N., Sfagos C., Anastasopoulos E., Reclos G. J., Papamichail M., Prothymosin- enhances HLA-DR antigen expression on monocytes from patients with multiple sclerosis Journal of Neuroimmunology 1990 27 2-3 141 147 (Pubitemid 20146282)
51. Baxevanis C. N., Reclos G. J., Economou M., Mechanism of action of prothymosin in the human autologous mixed lymphocyte response Immunopharmacology and Immunotoxicology 1988 10 4 443 461
52. Baxevanis C. N., Reclos G. J., Panneerselvam C., Papamichail M., Enhancement of human T lymphocyte functions by prothymosin. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses Immunopharmacology 1988 15 2 73 84
53. Di Francesco P., Pica F., Marini S., Favalli C., Garaci E., Thymosin one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration International Journal of Immunopharmacology 1992 14 1 1 9
54. Hsia J., Sarin N., Oliver J. H., Goldstein A. L., Aspirin and thymosin increase interleukin-2 and interferon- production by human peripheral blood lymphocytes Immunopharmacology 1989 17 3 167 173
55. Sztein M. B., Serrate S. A., Characterization of the immunoregulatory properties of thymosin 1 on interleukin-2 production and interleukin-2 receptor expression in normal human lymphocytes International Journal of Immunopharmacology 1989 11 7 789 800
56. Hall A. K., Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cells Anti-Cancer Drugs 1996 7 3 312 320
57. Markova O. V., Evstafieva A. G., Mansurova S. E., Cytochrome c is transformed from anti- to pro-oxidant when interacting with truncated oncoprotein prothymosin Biochimica et Biophysica Acta 2003 1557 13 109 117
58. Naz R. K., Kaplan P., Badamchian M., Goldstein A. L., Effects of synthetic thymosin- 1 and its analogs on fertilizability of human sperm: search for a biologically active, stable epitope Archives of Andrology 1995 35 1 63 69
59. Naz R. K., Menge A. C., Sacco A., Treatment with thymosin -1 increases fertilizing capacity of sperm of infertile men: a multicenter trial Archives of Andrology 1995 35 2 149 154